EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Current Drug Metabolism

Description
the international journal for timely in-depth reviews on drug metabolism

 

Status
active
Indexing
Journal Citation Reports/Science Edition, Science Citation Index-Expanded (SciSearch)TM, Biochemistry & Biophysics Citation IndexTM, Index to Scientific Reviews®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/Index Medicus, PubMed, EMBASE/Excerpta Medica, Scopus, PubsHub, Chemical Abstracts, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, J-Gate.
Subject

Source type
Journal
Publisher
ISBN ISSN
1389-2002
E ISSN
1875-5453
First volume
1
Last volume
17+
Publish city
Hilversum
Homepage
Description
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation, recent developments for the identification of drug metabolites, adducts and preclinical and clinical summaries of marketed drugs.


Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )